Published Technical Disclosure Archive

Synergistic Grafting Systems for Enhanced Surgical Outcomes

Publication ID: 24-11857419_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Grafting Systems for Enhanced Surgical Outcomes,” Published Technical Disclosure No. 24-11857419_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857419_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,419.

Summary of the Inventive Concept

The present invention integrates advanced technologies, such as AI, IoT, blockchain, and novel materials, with the original graft collar design to create a more powerful system for facilitating grafting in surgical procedures, enabling real-time analysis, optimized grafting techniques, and enhanced patient outcomes.

Background and Problem Solved

The original patent disclosed a graft collar design for facilitating grafting in surgical procedures. However, the limitations of the original design, such as the lack of real-time feedback and limited material options, hindered its full potential. The present invention addresses these limitations by incorporating synergistic technologies to create a more comprehensive and effective grafting system.

Detailed Description of the Inventive Concept

The synergistic grafting system comprises a graft collar with integrated sensors, IoT-enabled communication modules, and blockchain-enabled tracking systems. The system can transmit data to an AI-powered analytics platform for real-time analysis and feedback, enabling surgeons to optimize the grafting process. Additionally, the system can utilize novel, biocompatible materials with enhanced strength and durability, and can be used in conjunction with robotic assistance systems for precise and minimally invasive grafting. The system's components work in harmony to provide a more comprehensive and effective grafting solution.

Novelty and Inventive Step

The integration of AI, IoT, blockchain, and novel materials with the original graft collar design constitutes a novel and non-obvious inventive step, as it enables real-time analysis, optimized grafting techniques, and enhanced patient outcomes, which were not possible with the original design.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic grafting system could include the use of different sensor types, various IoT communication protocols, or alternative blockchain platforms. Additionally, the system could be adapted for use in different surgical procedures or with various types of graft materials.

Potential Commercial Applications and Market

The synergistic grafting system has significant commercial potential in the medical device industry, particularly in the fields of orthopedic and cardiovascular surgery. The system's ability to enhance patient outcomes, reduce complications, and improve surgical efficiency could lead to widespread adoption and market growth.

CPC Classifications

SectionClassGroup
A A61 A61F2/28
A A61 A61B17/8695
A A61 A61F2/3094
A A61 A61B17/7032
A A61 A61B17/8047
A A61 A61F2/446
A A61 A61F2002/2835
A A61 A61F2002/30115
A A61 A61F2310/00359

Field of Art

Surgical medical devices, specifically orthopedic grafting technologies involving bone fasteners, surgical implants, and minimally invasive surgical techniques with a focus on biomechanical integration and advanced medical instrumentation

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or orthopedic medical device designer with expertise in surgical implant design, advanced materials, sensor integration, and minimally invasive surgical technologies, holding advanced degrees in biomedical engineering or related fields with 5-10 years of industry experience

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies and advanced materials into existing surgical device designs represents a predictable evolution of medical device innovation. The source patent's foundational graft collar design provides a clear technical framework for incorporating sensor technologies, data tracking, and enhanced materials. The proposed variations represent logical extensions of existing medical device design principles, utilizing well-established technological integration strategies.

Obvious Combinations & Variations

Source Patent Element
Graft collar with engagement section for load-bearing bone fasteners
PTD Variation
Adding integrated sensors to detect biological structures and transmit data
Obviousness Reasoning
Sensor integration in medical devices is a known technique for enhancing diagnostic and procedural capabilities, representing a predictable application of existing technological approaches
Source Patent Element
Surgical grafting methodology with minimally invasive approach
PTD Variation
Incorporating IoT-enabled communication modules and blockchain tracking
Obviousness Reasoning
Digital tracking and communication technologies are standard approaches for improving medical device traceability and procedural documentation, constituting a routine design optimization
Source Patent Element
Graft collar with specific geometric configurations
PTD Variation
Utilizing novel biocompatible materials with enhanced strength and durability
Obviousness Reasoning
Material science advancements represent a predictable area of iterative improvement in medical device design, with finite known approaches for enhancing mechanical properties
Source Patent Element
Surgical grafting procedure design
PTD Variation
Integrating robotic assistance systems for precise minimally invasive grafting
Obviousness Reasoning
Robotic surgical assistance is a known technological approach for improving surgical precision, representing a logical extension of existing minimally invasive surgical methodologies
Source Patent Element
Surgical device design for bone grafting
PTD Variation
Implementing machine learning algorithms for personalized grafting recommendations
Obviousness Reasoning
AI-driven personalization in medical technologies is a recognized trend, representing a predictable application of data analysis techniques to surgical procedural optimization
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857419 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed synergistic grafting system variations obvious and non-inventive. The integration of digital technologies, advanced materials, and data-driven approaches represents a predictable evolutionary step in medical device design, lacking the requisite non-obviousness for patent protection.

Original Patent Information

Patent NumberUS 11,857,419
TitleMethods and apparatus for facilitating grafting in surgical procedures
Assignee(s)SAMARITAN BIOLOGICS, LLC